Similarly, in ALS patients, increased fasting and postprandial glucagon concentrations were coupled with reduced fasting glucose, indicating glucagon resistance in both patients and SOD1G93A mice. The gene discussed is GCG; the disease is amyotrophic lateral sclerosis.